Griffin R Kent Jr
Known title: DirectorCIK: 0001356944
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Healthpeak Sets Q3 2026 Earnings Date and Declares Q4 Dividend. Healthpeak Properties announced the dates for its third‑quarter 2026 earnings release, conference call, and webcast. The company also declared a monthly common‑stock cash dividend for the fourth quarter of 2026. These updates give investors a schedule for upcoming earnings and confirm the firm’s continued dividend payments, which can influence trading activity.
Transaction History
| CUZ | ▲ Buy | Grant | 4,186 | $105K | 6/1/2026 | View on chart |
| CUZ | ▲ Buy | Grant | 5,681 | $150K | 6/1/2026 | View on chart |
| DOC | ▲ Buy | Grant | 9,744 | $0 | 5/6/2026 | View on chart |
| CUZ | ▲ Buy | Grant | 4,802 | $135K | 6/2/2025 | View on chart |
| CUZ | ▲ Buy | Grant | 3,558 | $95K | 6/2/2025 | View on chart |
| DOC | ▲ Buy | Grant | 10,657 | $0 | 4/25/2025 | View on chart |
| CUZ | ▲ Buy | Grant | 5,836 | $135K | 5/31/2024 | View on chart |
| CUZ | ▲ Buy | Grant | 4,324 | $95K | 5/31/2024 | View on chart |
| DOC | ▲ Buy | Grant | 9,575 | $0 | 4/26/2024 | View on chart |
| CUZ | ▲ Buy | Grant | 4,624 | $87K | 5/31/2023 | View on chart |
| CUZ | ▲ Buy | Grant | 6,275 | $125K | 5/31/2023 | View on chart |
| DOC | ▲ Buy | Grant | 8,193 | $0 | 4/28/2023 | View on chart |
| CUZ | ▲ Buy | Grant | 3,617 | $125K | 5/31/2022 | View on chart |
| CUZ | ▲ Buy | Grant | 2,666 | $87K | 5/31/2022 | View on chart |
| DOC | ▲ Buy | Grant | 5,258 | $0 | 4/28/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
CUZ featured in value-stock comparison with NHI
A recent Yahoo Finance article compared Cousins Properties with National Health Investors as two candidates for value-focused portfolios. The piece highlights CUZ's elevated trailing P/E of 763.4 alongside a 6.47% dividend yield, framing the discussion around income versus valuation. With 11 analysts covering the stock and an average target of $33.64 against a 52-week range of $21.03 to $32.95, the comparison offers one snapshot for readers weighing these names side by side.
CUZ featured in value-stock comparison with NHI. A recent Yahoo Finance article compared Cousins Properties with National Health Investors as two candidates for value-focused portfolios. The piece highlights CUZ's elevated trailing P/E of 763.4 alongside a 6.47% dividend yield, framing the discussion around income versus valuation. With 11 analysts covering the stock and an average target of $33.64 against a 52-week range of $21.03 to $32.95, the comparison offers one snapshot for readers weighing these names side by side.